Kardium Stock

Kardium develops medical devices for the diagnosis and treatment of atrial fibrillation.

Sign up today and learn more about Kardium Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Kardium Stock

Kardium is a technology pioneer working to advance medical device technology in the diagnosis and treatment of atrial fibrillation. Kardium was founded in 2007 and has built an outstanding team with a track record of excellence in medicine, business, and engineering. We have hired the best engineers, medical researchers and production staff and have been working with a team of top medical advisors to develop the Globe mapping and ablation system. The Globe system has been entirely developed by the team at Kardium and provides a complete system to assist in the diagnosis and treatment of atrial fibrillation. Kardium is based in Vancouver, Canada, and has consistently ranked as one of the top companies to work for in British Columbia.

Funding History

August 2010$868K
April 2014$269K
January 2021$115M



John Yeung


John Webb

Co-Founder & Advisor

Sam Lichtenstein


Doug Goertzen


Hans Kottkamp


Amos Michelson


James Abel

Co-Founder & Advisor

Dan Gelbart


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: